Literature DB >> 30623462

Phrenic Nerve Conduction in Healthy Subjects.

Marjolaine Vincent1, Isabelle Court-Fortune1, Frédéric Costes2, Jean-Christophe Antoine3, Jean-Philippe Camdessanché3.   

Abstract

INTRODUCTION: Assessment of diaphragm compound muscle action potential by noninvasive phrenic nerve stimulation at the neck is well described. However, normal values in a large cohort of healthy subjects are lacking. Our objective was to determine reference values of phrenic nerve conduction in healthy subjects.
METHODS: We recruited 155 healthy subjects (25-79 years old) and measured mean amplitude (PhrenAmp) and latency (PhrenLat) of motor responses according to Bolton's method.
RESULTS: The lower limit for PhrenAmp was 0.28 and 0.25 mV and the upper limit for PhrenLat was 8.41 and 8.56 ms for right and left side, respectively. PhrenLat was correlated with age. PhrenAmp, PhrenLat and area were significantly higher in men. Tolerance to phrenic nerve stimulation was excellent.
CONCLUSIONS: Our study provides normative values of phrenic nerve motor responses in a large cohort of healthy subjects and identifies age and sex as factors of variation. Muscle Nerve 59:451-456, 2019.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Phrenic nerve conduction; healthy subjects; normative values

Mesh:

Year:  2019        PMID: 30623462     DOI: 10.1002/mus.26414

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  2 in total

1.  Differences between diaphragmatic compound muscle action potentials recorded from over the sternum and lateral chest wall in healthy subjects.

Authors:  Gihan Younis; Noha El Sawy; Rehab Elnemr; Doaa Madkour
Journal:  Sci Rep       Date:  2022-05-27       Impact factor: 4.996

2.  Diaphragm impairment in patients admitted for severe COVID-19.

Authors:  Laura López-Viñas; Juan Vega-Villar; Esmeralda Rocío-Martín; Patricia García-García; Elena De La Rosa Santiago; Jose María Galván-Román; Rybel Wix-Ramos
Journal:  Eur J Transl Myol       Date:  2022-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.